Soleno Therapeutics, Inc. (SLNO) Financials

SLNO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 180.7 million 23.2 million
2023-09-30 63.5 million 40.3 million
2023-06-30 30.9 million 18.5 million
2023-03-31 19.5 million 16.9 million

SLNO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.3 million 1.9 million
2023-09-30 -6.3 million 2.2 million
2023-06-30 -5.6 million 1.2 million
2023-03-31 -6.7 million 631000

SLNO Net Income

No data available :(

SLNO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 169.7 million - 403000
2023-09-30 52.4 million - 470000
2023-06-30 19.4 million - 485000
2023-03-31 7.9 million - 39000

SLNO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 34.4 million
2023-09-30 11.4 million
2023-06-30 10.4 million
2023-03-31 9.4 million

SLNO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 8.7 million 4.1 million 489000
2023-09-30 - 6.0 million 3.3 million -
2023-06-30 - 5.1 million 3.2 million -
2023-03-31 - 5.3 million 2.9 million -

SLNO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 489000
2023-09-30 - 557000
2023-06-30 - 598000
2023-03-31 - 568000

SLNO

Price: $45.12

52 week price:
3.00
53.82

Earnings Per Share: -2.36 USD

P/E Ratio: -15.10

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 110100

Ebitda: -13.8 million

Market Capitalization: 1.3 billion

Links: